This is further supported by NMDAR1-abs measurements of another stroke cohort (STRAWINSKI, Identifier NCT01264549), in which we measured the serostatus within 36 h after the stroke and observed a similar seroprevalence of IgA and IgM antibodies (data not published) as in the PROSCIS-B study. This evidence concerns the gene CD79A and stroke disorder.